Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

214 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Smoothened as a new therapeutic target for human osteosarcoma.
Hirotsu M, Setoguchi T, Sasaki H, Matsunoshita Y, Gao H, Nagao H, Kunigou O, Komiya S. Hirotsu M, et al. Among authors: setoguchi t. Mol Cancer. 2010 Jan 12;9:5. doi: 10.1186/1476-4598-9-5. Mol Cancer. 2010. PMID: 20067614 Free PMC article.
Inhibition of casein kinase 2 prevents growth of human osteosarcoma.
Takahashi K, Setoguchi T, Tsuru A, Saitoh Y, Nagano S, Ishidou Y, Maeda S, Furukawa T, Komiya S. Takahashi K, et al. Among authors: setoguchi t. Oncol Rep. 2017 Feb;37(2):1141-1147. doi: 10.3892/or.2016.5310. Epub 2016 Dec 9. Oncol Rep. 2017. PMID: 27959425
Tranilast enhances the effect of anticancer agents in osteosarcoma.
Nakashima T, Nagano S, Setoguchi T, Sasaki H, Saitoh Y, Maeda S, Komiya S, Taniguchi N. Nakashima T, et al. Among authors: setoguchi t. Oncol Rep. 2019 Jul;42(1):176-188. doi: 10.3892/or.2019.7150. Epub 2019 May 6. Oncol Rep. 2019. PMID: 31059083 Free PMC article.
Role of GLI2 in the growth of human osteosarcoma.
Nagao H, Ijiri K, Hirotsu M, Ishidou Y, Yamamoto T, Nagano S, Takizawa T, Nakashima K, Komiya S, Setoguchi T. Nagao H, et al. Among authors: setoguchi t. J Pathol. 2011 Jun;224(2):169-79. doi: 10.1002/path.2880. Epub 2011 Apr 19. J Pathol. 2011. PMID: 21506130
RBPJ is a novel target for rhabdomyosarcoma therapy.
Nagao H, Setoguchi T, Kitamoto S, Ishidou Y, Nagano S, Yokouchi M, Abematsu M, Kawabata N, Maeda S, Yonezawa S, Komiya S. Nagao H, et al. Among authors: setoguchi t. PLoS One. 2012;7(7):e39268. doi: 10.1371/journal.pone.0039268. Epub 2012 Jul 9. PLoS One. 2012. PMID: 22792167 Free PMC article.
214 results